2024-04-062025-04-052025-04-05false06938232NEW RIVER HEALTH LIMITED2025-11-26falseiso4217:GBPxbrli:pure069382322024-04-05069382322025-04-05069382322024-04-062025-04-05069382322023-04-05069382322024-04-05069382322023-04-062024-04-0506938232bus:SmallEntities2024-04-062025-04-0506938232bus:AuditExempt-NoAccountantsReport2024-04-062025-04-0506938232bus:FullAccounts2024-04-062025-04-0506938232bus:PrivateLimitedCompanyLtd2024-04-062025-04-0506938232core:WithinOneYear2025-04-0506938232core:AfterOneYear2025-04-0506938232core:WithinOneYear2024-04-0506938232core:AfterOneYear2024-04-0506938232core:ShareCapital2025-04-0506938232core:SharePremium2025-04-0506938232core:RevaluationReserve2025-04-0506938232core:OtherReservesSubtotal2025-04-0506938232core:RetainedEarningsAccumulatedLosses2025-04-0506938232core:ShareCapital2024-04-0506938232core:SharePremium2024-04-0506938232core:RevaluationReserve2024-04-0506938232core:OtherReservesSubtotal2024-04-0506938232core:RetainedEarningsAccumulatedLosses2024-04-0506938232core:LandBuildings2025-04-0506938232core:PlantMachinery2025-04-0506938232core:Vehicles2025-04-0506938232core:FurnitureFittings2025-04-0506938232core:OfficeEquipment2025-04-0506938232core:NetGoodwill2025-04-0506938232core:IntangibleAssetsOtherThanGoodwill2025-04-0506938232core:ListedExchangeTraded2025-04-0506938232core:UnlistedNon-exchangeTraded2025-04-0506938232core:LandBuildings2024-04-0506938232core:PlantMachinery2024-04-0506938232core:Vehicles2024-04-0506938232core:FurnitureFittings2024-04-0506938232core:OfficeEquipment2024-04-0506938232core:NetGoodwill2024-04-0506938232core:IntangibleAssetsOtherThanGoodwill2024-04-0506938232core:ListedExchangeTraded2024-04-0506938232core:UnlistedNon-exchangeTraded2024-04-0506938232core:LandBuildings2024-04-062025-04-0506938232core:PlantMachinery2024-04-062025-04-0506938232core:Vehicles2024-04-062025-04-0506938232core:FurnitureFittings2024-04-062025-04-0506938232core:OfficeEquipment2024-04-062025-04-0506938232core:NetGoodwill2024-04-062025-04-0506938232core:IntangibleAssetsOtherThanGoodwill2024-04-062025-04-0506938232core:ListedExchangeTraded2024-04-062025-04-0506938232core:UnlistedNon-exchangeTraded2024-04-062025-04-0506938232core:MoreThanFiveYears2024-04-062025-04-0506938232core:Non-currentFinancialInstruments2025-04-0506938232core:Non-currentFinancialInstruments2024-04-0506938232dpl:CostSales2024-04-062025-04-0506938232dpl:DistributionCosts2024-04-062025-04-0506938232core:LandBuildings2024-04-062025-04-0506938232core:PlantMachinery2024-04-062025-04-0506938232core:Vehicles2024-04-062025-04-0506938232core:FurnitureFittings2024-04-062025-04-0506938232core:OfficeEquipment2024-04-062025-04-0506938232dpl:AdministrativeExpenses2024-04-062025-04-0506938232core:NetGoodwill2024-04-062025-04-0506938232core:IntangibleAssetsOtherThanGoodwill2024-04-062025-04-0506938232dpl:GroupUndertakings2024-04-062025-04-0506938232dpl:ParticipatingInterests2024-04-062025-04-0506938232dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-062025-04-0506938232core:ListedExchangeTraded2024-04-062025-04-0506938232dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-062025-04-0506938232core:UnlistedNon-exchangeTraded2024-04-062025-04-0506938232dpl:CostSales2023-04-062024-04-0506938232dpl:DistributionCosts2023-04-062024-04-0506938232core:LandBuildings2023-04-062024-04-0506938232core:PlantMachinery2023-04-062024-04-0506938232core:Vehicles2023-04-062024-04-0506938232core:FurnitureFittings2023-04-062024-04-0506938232core:OfficeEquipment2023-04-062024-04-0506938232dpl:AdministrativeExpenses2023-04-062024-04-0506938232core:NetGoodwill2023-04-062024-04-0506938232core:IntangibleAssetsOtherThanGoodwill2023-04-062024-04-0506938232dpl:GroupUndertakings2023-04-062024-04-0506938232dpl:ParticipatingInterests2023-04-062024-04-0506938232dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-062024-04-0506938232core:ListedExchangeTraded2023-04-062024-04-0506938232dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-062024-04-0506938232core:UnlistedNon-exchangeTraded2023-04-062024-04-0506938232core:NetGoodwill2025-04-0506938232core:IntangibleAssetsOtherThanGoodwill2025-04-0506938232core:LandBuildings2025-04-0506938232core:PlantMachinery2025-04-0506938232core:Vehicles2025-04-0506938232core:FurnitureFittings2025-04-0506938232core:OfficeEquipment2025-04-0506938232core:AfterOneYear2025-04-0506938232core:WithinOneYear2025-04-0506938232core:ListedExchangeTraded2025-04-0506938232core:UnlistedNon-exchangeTraded2025-04-0506938232core:ShareCapital2025-04-0506938232core:SharePremium2025-04-0506938232core:RevaluationReserve2025-04-0506938232core:OtherReservesSubtotal2025-04-0506938232core:RetainedEarningsAccumulatedLosses2025-04-0506938232core:NetGoodwill2024-04-0506938232core:IntangibleAssetsOtherThanGoodwill2024-04-0506938232core:LandBuildings2024-04-0506938232core:PlantMachinery2024-04-0506938232core:Vehicles2024-04-0506938232core:FurnitureFittings2024-04-0506938232core:OfficeEquipment2024-04-0506938232core:AfterOneYear2024-04-0506938232core:WithinOneYear2024-04-0506938232core:ListedExchangeTraded2024-04-0506938232core:UnlistedNon-exchangeTraded2024-04-0506938232core:ShareCapital2024-04-0506938232core:SharePremium2024-04-0506938232core:RevaluationReserve2024-04-0506938232core:OtherReservesSubtotal2024-04-0506938232core:RetainedEarningsAccumulatedLosses2024-04-0506938232core:NetGoodwill2023-04-0506938232core:IntangibleAssetsOtherThanGoodwill2023-04-0506938232core:LandBuildings2023-04-0506938232core:PlantMachinery2023-04-0506938232core:Vehicles2023-04-0506938232core:FurnitureFittings2023-04-0506938232core:OfficeEquipment2023-04-0506938232core:AfterOneYear2023-04-0506938232core:WithinOneYear2023-04-0506938232core:ListedExchangeTraded2023-04-0506938232core:UnlistedNon-exchangeTraded2023-04-0506938232core:ShareCapital2023-04-0506938232core:SharePremium2023-04-0506938232core:RevaluationReserve2023-04-0506938232core:OtherReservesSubtotal2023-04-0506938232core:RetainedEarningsAccumulatedLosses2023-04-0506938232core:AfterOneYear2024-04-062025-04-0506938232core:WithinOneYear2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:CostValuation2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-062025-04-0506938232core:Non-currentFinancialInstrumentscore:CostValuation2025-04-0506938232core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-0506938232core:Non-currentFinancialInstrumentscore:CostValuation2024-04-0506938232core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-0506938232core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-0506938232bus:Director12024-04-062025-04-0506938232bus:Director22024-04-062025-04-0506938232bus:Director32024-04-062025-04-0506938232bus:Director42024-04-062025-04-0506938232bus:Director52024-04-062025-04-0506938232core:FurnitureFittingsToolsEquipment2024-04-0506938232core:FurnitureFittingsToolsEquipment2024-04-062025-04-0506938232core:FurnitureFittingsToolsEquipment2025-04-05

NEW RIVER HEALTH LIMITED

Registered Number
06938232
(England and Wales)

Unaudited Financial Statements for the Year ended
5 April 2025

NEW RIVER HEALTH LIMITED
Company Information
for the year from 6 April 2024 to 5 April 2025

Directors

FLETCHER, Ian Harris, Dr
NOLAN WORNELL, Frances, Dr
NOOR, Rizwana, Dr
PATEL, Sanjay, Dr
STERN, Glenn, Dr

Company Secretary

PATEL, Sanjay, Dr

Registered Address

Ramsay Brown Llp The Brentano Suite
Solar House, 915 High Road
North Finchley
N12 8QJ

Registered Number

06938232 (England and Wales)
NEW RIVER HEALTH LIMITED
Balance Sheet as at
5 April 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets333,33049,997
Tangible assets4569,04019,580
602,37069,577
Current assets
Stocks5135,000134,197
Debtors6519,568361,666
Cash at bank and on hand290,373890,619
944,9411,386,482
Creditors amounts falling due within one year7(693,402)(259,107)
Net current assets (liabilities)251,5391,127,375
Total assets less current liabilities853,9091,196,952
Net assets853,9091,196,952
Capital and reserves
Called up share capital8,5008,500
Profit and loss account845,4091,188,452
Shareholders' funds853,9091,196,952
The financial statements were approved and authorised for issue by the Board of Directors on 26 November 2025, and are signed on its behalf by:
PATEL, Sanjay, Dr
Director
Registered Company No. 06938232
NEW RIVER HEALTH LIMITED
Notes to the Financial Statements
for the year ended 5 April 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Intangible assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation. Patents Lloyds Pharmacy License is stated at cost less accumulated depreciation and any accumulated impairment losses. It is amortised on a straightline method at 6.66%. If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new expectations.
Tangible fixed assets and depreciation
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straightline method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis. Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings15-
Office Equipment-25
Stocks and work in progress
Stocks are measured at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.Average number of employees

20252024
Average number of employees during the year1211
3.Intangible assets

Other

Total

££
Cost or valuation
At 06 April 24250,000250,000
At 05 April 25250,000250,000
Amortisation and impairment
At 06 April 24200,003200,003
Charge for year16,66716,667
At 05 April 25216,670216,670
Net book value
At 05 April 2533,33033,330
At 05 April 2449,99749,997
4.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 06 April 24-191,5665,882197,448
Additions551,450-1,151552,601
At 05 April 25551,450191,5667,033750,049
Depreciation and impairment
At 06 April 24-172,4505,418177,868
Charge for year-2,8672743,141
At 05 April 25-175,3175,692181,009
Net book value
At 05 April 25551,45016,2491,341569,040
At 05 April 24-19,11646419,580
5.Stocks

2025

2024

££
Raw materials and consumables135,000134,197
Total135,000134,197
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables358,713169,460
Other debtors154,503183,706
Called up share capital not paid, current asset-8,500
Prepayments and accrued income6,352-
Total519,568361,666
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables525,597139,990
Taxation and social security-116,210
Payments received on account164,725-
Accrued liabilities and deferred income3,0802,907
Total693,402259,107
8.Related party transactions
As at the year end, the company was owed by Green Lanes Medical LLP £Nil (2024: £125,000), a partnership in which the directors of the company are members. Interest is chargeable at 3.1% per annum.
9.Controlling party
The company was controlled throughout the year by its directors.